Skip to main content
. 2022 Aug 6;10(8):1267. doi: 10.3390/vaccines10081267

Figure 1.

Figure 1

Schematic overview of groups of patients Four groups of participants were included. Group 1-3 had received ChAdOx1 nCoV-19 vaccination (first dose) and experienced complications of different levels of severity. Group 4 consisted of non-vaccinated healthy blood donor controls from pre-COVID era (2015).